Abstract
Obstructive sleep apnea (OSA) is a common chronic breathing disorder associated with reduced quality of life. Given the rising prevalence of obesity, the leading risk factor for this condition, OSA is an important public health concern. Noninvasive continuous positive airway pressure (CPAP) is first-line therapy for OSA. Despite the benefits of consistent CPAP use, adherence remains a challenge. CPAP machines and accessories are sold in community pharmacies and home healthcare settings. It is increasingly important that pharmacists understand the principles of OSA and CPAP therapy to optimize pharmacotherapy with this disorder and reinforce CPAP compliance.
| Original language | English |
|---|---|
| Pages | 30-33 |
| Number of pages | 4 |
| Volume | 40 |
| No | 1 |
| Specialist publication | U.S. Pharmacist |
| State | Published - Jan 1 2015 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science
- Pharmacology
- Pharmacy
Cite this
Obstructive sleep apnea and continuous positive airway pressure : A primer for pharmacists. / Au, Trang H.; Castillo, Shana L.; Morrow, Lee E.; Malesker, Mark A.
In: U.S. Pharmacist, Vol. 40, No. 1, 01.01.2015, p. 30-33.Research output: Contribution to specialist publication › Article
}
TY - GEN
T1 - Obstructive sleep apnea and continuous positive airway pressure
T2 - A primer for pharmacists
AU - Au, Trang H.
AU - Castillo, Shana L.
AU - Morrow, Lee E.
AU - Malesker, Mark A.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Obstructive sleep apnea (OSA) is a common chronic breathing disorder associated with reduced quality of life. Given the rising prevalence of obesity, the leading risk factor for this condition, OSA is an important public health concern. Noninvasive continuous positive airway pressure (CPAP) is first-line therapy for OSA. Despite the benefits of consistent CPAP use, adherence remains a challenge. CPAP machines and accessories are sold in community pharmacies and home healthcare settings. It is increasingly important that pharmacists understand the principles of OSA and CPAP therapy to optimize pharmacotherapy with this disorder and reinforce CPAP compliance.
AB - Obstructive sleep apnea (OSA) is a common chronic breathing disorder associated with reduced quality of life. Given the rising prevalence of obesity, the leading risk factor for this condition, OSA is an important public health concern. Noninvasive continuous positive airway pressure (CPAP) is first-line therapy for OSA. Despite the benefits of consistent CPAP use, adherence remains a challenge. CPAP machines and accessories are sold in community pharmacies and home healthcare settings. It is increasingly important that pharmacists understand the principles of OSA and CPAP therapy to optimize pharmacotherapy with this disorder and reinforce CPAP compliance.
UR - http://www.scopus.com/inward/record.url?scp=84921850090&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921850090&partnerID=8YFLogxK
M3 - Article
VL - 40
SP - 30
EP - 33
JO - U.S. Pharmacist
JF - U.S. Pharmacist
SN - 0148-4818
ER -